MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2021.01.002

Медицинская библиотека · American heart journal · 2021

Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial.

Thiele Holger, Freund Anne, Gimenez Maria Rubini, de Waha-Thiele Suzanne, Akin Ibrahim, Pöss Janine, Feistritzer Hans-Josef, Fuernau Georg, Graf Tobias, Nef Holger, Hamm Christian, Böhm Michael, Lauten Alexander, Schulze P Christian, Voigt Ingo, Nordbeck Peter, Felix Stephan B, Abel Peter, Baldus Stephan, Laufs Ulrich, Lenk Karsten, Landmesser Ulf, Skurk Carsten, Pieske Burkert, Tschöpe Carsten, Hennersdorf Marcus, Wengenmayer Tobias, Preusch Michael, Maier Lars S, Jung Christian, Kelm Malte, Clemmensen Peter, Westermann Dirk, Seidler Tim, Schieffer Bernhard, Rassaf Tienush, Mahabadi Amir-Abbas, Vasa-Nicotera Mariuca, Meincke Felix, Seyfarth Melchior, Kersten Alexander, Rottbauer Wolfgang, Boekstegers Peter, Muellenbach Ralf, Dengler Thomas, Kadel Christoph, Schempf Benjamin, Karagiannidis Christian, Hopf Hans-Bernd, Lehmann Ralf, Bufe Alexander, Baumanns Stefan, Öner Alper, Linke Axel, Sedding Daniel, Ferrari Markus, Bruch Leonhard, Goldmann Britta, John Stefan, Möllmann Helge, Franz Jutta, Lapp Harald, Lauten Philipp, Noc Marko, Goslar Tomaz, Oerlecke Ilka, Ouarrak Taoufik, Schneider Steffen, Desch Steffen, Zeymer Uwe, ECLS-SHOCK Investigators

Протокол клинического исследованияСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

In acute myocardial infarction complicated by cardiogenic shock the use of mechanical circulatory support devices remains controversial and data from randomized clinical trials are very limited. Extracorporeal life support (ECLS) - venoarterial extracorporeal membrane oxygenation - provides the strongest hemodynamic support in addition to oxygenation. However, despite increasing use it has not yet been properly investigated in randomized trials. Therefore, a prospective randomized adequately powered clinical trial is warranted.

STUDY

DESIGN

The ECLS-SHOCK trial is a 420-patient controlled, international, multicenter, randomized, open-label trial. It is designed to compare whether treatment with ECLS in addition to early revascularization with percutaneous coronary intervention or alternatively coronary artery bypass grafting and optimal medical treatment is beneficial in comparison to no-ECLS in patients with severe infarct-related cardiogenic shock. Patients will be randomized in a 1:1 fashion to one of the two treatment arms. The primary efficacy endpoint of ECLS-SHOCK is 30-day mortality. Secondary outcome measures such as hemodynamic, laboratory, and clinical parameters will serve as surrogate endpoints for prognosis. Furthermore, a longer follow-up at 6 and 12 months will be performed including quality of life assessment. Safety endpoints include peripheral ischemic vascular complications, bleeding and stroke.

CONCLUSIONS

The ECLS-SHOCK trial will address essential questions of efficacy and safety of ECLS in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock.

Для цитирования: Thiele Holger, Freund Anne, Gimenez Maria Rubini, de Waha-Thiele Suzanne, Akin Ibrahim, Pöss Janine, Feistritzer Hans-Josef, Fuernau Georg, Graf Tobias, Nef Holger, Hamm Christian, Böhm Michael, Lauten Alexander, Schulze P Christian, Voigt Ingo, Nordbeck Peter, Felix Stephan B, Abel Peter, Baldus Stephan, Laufs Ulrich, Lenk Karsten, Landmesser Ulf, Skurk Carsten, Pieske Burkert, Tschöpe Carsten, Hennersdorf Marcus, Wengenmayer Tobias, Preusch Michael, Maier Lars S, Jung Christian, Kelm Malte, Clemmensen Peter, Westermann Dirk, Seidler Tim, Schieffer Bernhard, Rassaf Tienush, Mahabadi Amir-Abbas, Vasa-Nicotera Mariuca, Meincke Felix, Seyfarth Melchior, Kersten Alexander, Rottbauer Wolfgang, Boekstegers Peter, Muellenbach Ralf, Dengler Thomas, Kadel Christoph, Schempf Benjamin, Karagiannidis Christian, Hopf Hans-Bernd, Lehmann Ralf, Bufe Alexander, Baumanns Stefan, Öner Alper, Linke Axel, Sedding Daniel, Ferrari Markus, Bruch Leonhard, Goldmann Britta, John Stefan, Möllmann Helge, Franz Jutta, Lapp Harald, Lauten Philipp, Noc Marko, Goslar Tomaz, Oerlecke Ilka, Ouarrak Taoufik, Schneider Steffen, Desch Steffen, Zeymer Uwe, ECLS-SHOCK Investigators. Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial.. American heart journal. 2021. DOI: 10.1016/j.ahj.2021.01.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.